Recently, it was reported that EGCG inhibited programmed cell death ligand 1 (PD-L1) expression in NSCLC cells, induced by both interferon (IFN)-γ and epidermal growth factor (EGF) [7]. This evidence concerns the gene EGF and non-small cell lung carcinoma.